These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30690212)

  • 1. Challenging MDR-TB clinical problems - The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs.
    Tiberi S; Pontali E; Tadolini M; D'Ambrosio L; Migliori GB
    Int J Infect Dis; 2019 Mar; 80S():S68-S72. PubMed ID: 30690212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
    Guglielmetti L; Jaffré J; Bernard C; Brossier F; El Helali N; Chadelat K; Thouvenin G; Dautzenberg B; Henry B; Jaspard M; Guillot H; Pourcher V; Le Dû D; Marigot-Outtandy D; Mougari F; Raskine L; Rivoire B; Andrejak C; Jarlier V; Aubry A; Robert J; Frechet-Jachym M; Veziris N
    Int J Tuberc Lung Dis; 2019 Oct; 23(10):1050-1054. PubMed ID: 31627768
    [No Abstract]   [Full Text] [Related]  

  • 3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistant tuberculosis: trends and control.
    Prasad R; Gupta N; Singh M
    Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of multidrug-resistant tuberculosis in the 21st century.
    Kaul G; Kapoor E; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Mar; 55(3):215-224. PubMed ID: 30938375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda.
    Baluku JB; Katuramu R; Naloka J; Kizito E; Nabwana M; Bongomin F
    BMC Pulm Med; 2021 Jul; 21(1):220. PubMed ID: 34246234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.
    Seaworth BJ; Griffith DE
    Microbiol Spectr; 2017 Mar; 5(2):. PubMed ID: 28361737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug resistant tuberculosis].
    Zwolska Z; Augustynowicz-Kopeć E
    Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives.
    Lessem E; Cox H; Daniels C; Furin J; McKenna L; Mitnick CD; Mosidi T; Reed C; Seaworth B; Stillo J; Tisile P; von Delft D
    Int J Infect Dis; 2015 Mar; 32():56-60. PubMed ID: 25809757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use.
    Hafkin J; Hittel N; Martin A; Gupta R
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
    Yuen CM; Kurbatova EV; Tupasi T; Caoili JC; Van Der Walt M; Kvasnovsky C; Yagui M; Bayona J; Contreras C; Leimane V; Ershova J; Via LE; Kim H; Akksilp S; Kazennyy BY; Volchenkov GV; Jou R; Kliiman K; Demikhova OV; Vasilyeva IA; Dalton T; Cegielski JP
    PLoS Med; 2015 Dec; 12(12):e1001932. PubMed ID: 26714320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Multidrug-resistant Tuberculosis.
    Rumende CM
    Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Multidrug-Resistant Tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2018 Jun; 39(3):310-324. PubMed ID: 30071546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of drug resistantTB in patients with HIV co-infection.
    Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond.
    D'Ambrosio L; Bothamley G; Caminero Luna JA; Duarte R; Guglielmetti L; Muñoz Torrico M; Payen MC; Saavedra Herrera N; Salazar Lezama MA; Skrahina A; Tadolini M; Tiberi S; Veziris N; Migliori GB
    Pulmonology; 2018; 24(2):132-141. PubMed ID: 29229274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.